Merck & Co. Inc.
[WKN: A0YD8Q | ISIN: US58933Y1055]
Aktienkurse
101,930$ -0,38%
Echtzeit-Aktienkurs Merck & Co. Inc.
Bid: Ask:
Reuters Kategorien
dpa-AFX Compact / dpa-AFX PRO Kategorien
Traderfox: dpa-AFX ProFeed Kategorien
dpa-AFX ProFeed Kategorien

BioStock: Aqilion and Merck sever ties

Aqilion announced the termination of the licensing and collaboration agreement with Merck for the joint development of the TAK1 programme taking aim at chronic inflammation.…

JEFFERIES stuft MERCK KGAA auf Buy

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Merck KGaA nach der Einstellung zweier Phase-III-Studien mit…

Aqilion regains rights to TAK1 program

AQILION AB (publ) announces that Aqilion and Merck have decided to terminate the joint development of the TAK1 program. Data…